Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M M Strijbis

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis and Related Disorders|March 20, 2026
Safety and patient experiences with the natalizumab biosimilar in multiple sclerosis treatmentLiza M Y Gelissen, Eva M M Strijbis, Bob W van Oosten, et al.
Neuroimage. Clinical|February 20, 2026
Longitudinal MRI-based changes in intracranial volume and skull thickness observed in both metachromatic leukodystrophy and multiple sclerosisGuus H J Vorst, Nicole I Wolf, David R van Nederpelt, et al.
Neurology|December 18, 2025
Association of Brain Age With Physical Disability and Cognitive Impairment in People With Multiple Sclerosis of the Same AgeLonneke Bos, Alle Meije Wink, James H Cole, et al.
Frontiers in Neuroscience|July 5, 2022
State Changes During Resting-State (Magneto)encephalographic Studies: The Effect of Drowsiness on Spectral, Connectivity, and Network AnalysesEva M M Strijbis, Yannick S S Timar, Deborah N Schoonhoven, et al.
Neurology|December 6, 2024
Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial DatasetsMarcus Werner Koch, Lorraine V Kalia, Justyna R Sarna, et al.
Journal of Neurology|December 23, 2022
Adipokines in multiple sclerosis patients are related to clinical and radiological measuresFloor C Loonstra, Kim F Falize, Lodewijk R J de Ruiter, et al.
Brain Sciences|January 22, 2024
Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional StudySezgi Kaçar, Danko Coric, Giovanni Ometto, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Enhancing the interpretability of spinal cord atrophy in multiple sclerosis by reducing interindividual variability due to anatomical differencesDaan J de Jong, Tom A Fuchs, Mar Barrantes-Cepas, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Project Y: The search for clues explaining phenotype variability in MSFloor C Loonstra, Lodewijk R J De Ruiter, Djoeke Doesburg, et al.
Neurobiology of Aging|August 14, 2012
Histone deacetylase gene variants predict brain volume changes in multiple sclerosisBecky Inkster, Eva M M Strijbis, Maria Vounou, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis and Related Disorders|March 20, 2026
Safety and patient experiences with the natalizumab biosimilar in multiple sclerosis treatmentLiza M Y Gelissen, Eva M M Strijbis, Bob W van Oosten, et al.
Neuroimage. Clinical|February 20, 2026
Longitudinal MRI-based changes in intracranial volume and skull thickness observed in both metachromatic leukodystrophy and multiple sclerosisGuus H J Vorst, Nicole I Wolf, David R van Nederpelt, et al.
Neurology|December 18, 2025
Association of Brain Age With Physical Disability and Cognitive Impairment in People With Multiple Sclerosis of the Same AgeLonneke Bos, Alle Meije Wink, James H Cole, et al.
Frontiers in Neuroscience|July 5, 2022
State Changes During Resting-State (Magneto)encephalographic Studies: The Effect of Drowsiness on Spectral, Connectivity, and Network AnalysesEva M M Strijbis, Yannick S S Timar, Deborah N Schoonhoven, et al.
Neurology|December 6, 2024
Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial DatasetsMarcus Werner Koch, Lorraine V Kalia, Justyna R Sarna, et al.
Journal of Neurology|December 23, 2022
Adipokines in multiple sclerosis patients are related to clinical and radiological measuresFloor C Loonstra, Kim F Falize, Lodewijk R J de Ruiter, et al.
Brain Sciences|January 22, 2024
Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional StudySezgi Kaçar, Danko Coric, Giovanni Ometto, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Enhancing the interpretability of spinal cord atrophy in multiple sclerosis by reducing interindividual variability due to anatomical differencesDaan J de Jong, Tom A Fuchs, Mar Barrantes-Cepas, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Project Y: The search for clues explaining phenotype variability in MSFloor C Loonstra, Lodewijk R J De Ruiter, Djoeke Doesburg, et al.
Neurobiology of Aging|August 14, 2012
Histone deacetylase gene variants predict brain volume changes in multiple sclerosisBecky Inkster, Eva M M Strijbis, Maria Vounou, et al.
Pageof 6